Clinical Trial Update: Quality of Life as a Predictor of OS and PFS in Patients With Lung Cancer

View source ↗

Summary

The trial update discusses analyzing quality of life as a potential predictor of overall survival and progression-free survival in patients with lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: Instituto Nacional de Cancerologia, Columbia | Conditions: Lung Cancers, Lung Cancer, Non-Small Cell | Status: ACTIVE_NOT_RECRUITING